why is bpc-157 illegal Understanding the Legal Risks of and Other Unapproved Peptides – Holt Law BPC-157: Experimental Peptide Creates Risk
Description
Prevalence of pelvic floor dysfunction in patients with interstitial cystitis
Published November 17, 2010
Really simple
In the AKI subgroup, the mortality rate was 8.8%, while in the non-AKI subgroup, the mortality rate was 0.7% [112]
Michielan A, DInc R
